$MIST
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in MontrΓ©al, Canada.
Healthcare
Sector
Biotechnology
Industry
Joseph G. Oliveto
CEO
33
Employees
$1.70
Current Price
$142.23M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 5 | $159,105.34 | 82,438 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 7 | $256,980.34 | 125,938 | ||
See activity going back 12 months β create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jan 26, 2026 | Bharucha David Chief Medical Officer | Sale | 12,245 | $1.93 | $23,632.85 | View Details |
| Jan 26, 2026 | Nelson Jeffrey Edward Chief Operating Officer | Sale | 12,245 | $1.93 | $23,632.85 | View Details |
| Jan 26, 2026 | Muller Lorenz Chief Commercial Officer | Sale | 11,180 | $1.93 | $21,577.40 | View Details |
| Jan 26, 2026 | Hasija Amit CFO & EVP of Corp. Development | Sale | 12,245 | $1.93 | $23,632.85 | View Details |
| Jan 26, 2026 | Oliveto Joseph Director | Sale | 34,523 | $1.93 | $66,629.39 | View Details |
| Jan 8, 2026 | Oliveto Joseph Director | Sale | 43,000 | $2.25 | $96,750.00 | View Details |
| Jan 7, 2026 | Oliveto Joseph Director | Sale | 500 | $2.25 | $1,125.00 | View Details |
5 more transactions available β create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$0.16
ActualN/A
Revenue
EstimatedN/A
ActualN/A
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Past Earnings
Historical earnings results
EPS
Estimated-$0.16
Actual-$0.16
Beat
Revenue
Estimated$37.52M
Actual$1.44M
Miss
EPS
Estimated-$0.18
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available β create a free account to see 12 months of history